Roles
- Director, Immunocompromised Host Section, Division of Infectious Diseases
- Medical Director, Infection Control & Antimicrobial Stewardship, Sylvester Cancer Center
- Director, Transplant Infectious Diseases Fellowship
- Professor of Clinical Medicine
-
Biography
Michele Ilene Morris, M.D., FIDSA, FAST is a Professor of Clinical Medicine and director of the Immunocompromised Host Section in the Division of Infectious Diseases at the University of Miami Miller School of Medicine. She has spent the last 20 years of her career focusing her clinical practice and research efforts on transplant infectious diseases, with special attention to the area of emerging infections in transplant. Dr. Morris is also medical director of Infection Control and Antimicrobial Stewardship at Sylvester Cancer Center, and fellowship director of the Transplant Infectious Diseases fellowship at the University of Miami/Jackson Memorial Hospital. She has published over 100 peer-reviewed articles and 8 book chapters. She is a senior editor of the Emerging Transplant Infections textbook, published in 2021. Dr. Morris has delivered numerous presentations at national and international meetings, including invited lectures on five continents. She is a past president of the Transplantation Society’s Transplant Infectious Disease Section. She is an active member of the American Society of Transplantation’s Infectious Diseases Community of Practice (ID-COP) and a previous executive board member. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Teaching Interests
My work as an educator is focused on teaching learners of all types to recognize and manage the infectious complications experienced by the growing population of immunocompromised patients. I participate in educational programs designed to train nurses, nurse practitioners, pharmacists, pharmacy and medical students, residents, and fellows, as well as colleagues and family members. I am the medical director of the University of Miami/Jackson Memorial Hospital Transplant Infectious Diseases fellowship program and a key faculty member in the general Infectious Diseases fellowship. It is my hope that my work will help train the next generation of caregivers to better care for this vulnerable patient population -
Research Interests
My clinical research focuses on the diagnosis and management of invasive fungal and mycobacterial infections and the prevention and treatment of transplant-related infectious diseases, with special attention to the area of emerging infections in transplant. I have collaborated with colleagues at other centers to develop guidelines for the screening and management of infectious diseases including seasonal and geographically endemic infections. My work has extended to transmissible infections in the transplant donor, for which I have participated in the development of donor screening and recipient management guidelines. I have been involved with several multi-center clinical and observational studies, including the NIAID-sponsored HOPE study, and multi-center studies of Zika virus infection. Currently I am actively investigating cytomegalovirus (CMV) risk factors and infection prevention in solid organ and stem cell transplant recipients. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Articles & News
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
- Principal Investigator: Michele Morris
- Study Phase: N/A
- Enrollment Status: Closed
-
A Phase 3 Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Letermovir (LET) Prophylaxis When Extended From 100 Days to 200 Days Post-transplant in Cytomegalovirus (CMV) Seropositive Recipients (R+) of an Allogenic Hematopoietic Stem Cell Transplant (HSCT)
- Principal Investigator: Michele Morris
- Study Phase: Phase 3
- Enrollment Status: Closed